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Over the past several years, the epidemiological proﬁle of dengue has been changing
progressively  and is currently characterized by an increase in the number of cases in
children  under 15 years of age. This study was aimed at comparing the clinical and lab-
oratory  features between adults and children with dengue; therefore, we performed a
cross-sectional analysis of 5686 individuals with laboratory-conﬁrmed dengue who sought
treatment  at a healthcare facility in Rio de Janeiro, Brazil from 2010 to 2011. A multi-
variate  analysis indicated that myalgia (OR = 2.58; CI 95% = 2.08–3.18), retro-orbital pain
(OR  = 1.36; CI 95% = 1.15–1.62), nausea (OR = 1.92; CI 95% = 1.60–2.30), and arthralgia (OR = 3.64;
CI  95% = 2.72–4.89) were the most frequent clinical symptoms in adults, whereas vomiting
(OR  = 0.52; CI 95% = 0.43–0.61) and skin rash (OR = 0.46; CI 95% = 0.25–0.85) were  the most
prevalent  symptoms in children. Adults exhibited a higher hemoconcentration (OR = 3.04;
CI  95% = 2.53–3.65), thrombocytopenia (OR = 2.17; CI 95% = 1.80–2.60), increased erythro-
cyte  sedimentation rate (OR = 1.81; CI 95% = 1.53–2.14), and increased ALT (OR = 3.13; CI
95%  = 2.44–4.02) than did children. In addition, adults exhibited a higher frequency of the
severe  forms of the disease (OR = 1.74; CI 95% = 1.12–2.72) and hospitalization (OR = 2.21; CI95% = 1.59–3.06) relative to children. Based on these results, this study demonstrated signif-
icant  differences in the clinical and laboratory presentations and disease severity between
adults  and children affected by dengue.
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viral disease and is one of the most signiﬁcant diseases
because it is associated with high rates of morbidity and
mortality.1–3
e CC BY-NC-ND
 i s . 228  b r a z j i n f e c t d
This disease currently represents a major public health
issue,  especially in tropical and subtropical countries, where
environmental conditions enable the development and prolif-
eration  of the mosquito Aedes aegypti, which is the main vector
of  DENV.4,5
Dengue epidemiology has been changing in Brazil, with a
shift  being observed in the age group of the affected popula-
tion.  Currently, at least 25% of notiﬁed dengue cases occur in
children  who are 15 years of age or younger.6,7
The clinical manifestations of dengue vary from a non-
speciﬁc  febrile disease to a more  severe form with bleeding,
thrombocytopenia, and plasma extravasation, which can
result  in death. In children, dengue can be asymptomatic
or polysymptomatic, which may  hinder the differential
diagnosis.8,9
An early clinical diagnosis of dengue hemorrhagic fever
is  difﬁcult because the criteria that were established by the
World  Health Organization (WHO) may  be present only in the
initial  phase of the acute form of the disease.4 Thus, laboratory
tests  combined with a guided clinical examination, especially
in  endemic areas, are crucial to conﬁrm a diagnosis, identify,
and  prevent outbreaks and provide early treatment for the
severe  forms of the disease and complications.9
There are few reports on the clinical and laboratory differ-
ences  in children (0–14 years of age) and adults with dengue.10
Thus, this study aimed to determine the differences among
individuals with dengue who  were admitted to the Reference
Center  for Dengue (Centro de Referência da Dengue, CRD) in
Campos  dos Goytacazes, Rio de Janeiro.
Material  and  methods
Study  design  and  subjects
This study was  a cross-sectional, retrospective analysis that
was  conducted at the Reference Center for Dengue (Centro
de  Referência da Dengue, CRD), which is located at Campos
dos  Goytacazes city, Rio de Janeiro, Brazil. The medical records
of  all of the individuals who  were admitted to the CRD from
January  2010 to September 2011 were evaluated. The CRD Eval-
uation  Protocol was  used as a tool for data collection, which
consists  of a questionnaire on the epidemiological, clinical,
and  laboratory data that were collected during the ﬁrst med-
ical  visit. Individuals with a dengue diagnosis that was  based
on  clinical and serological criteria were included in the study.
Deﬁnitions
Suspected cases of dengue were deﬁned as individuals who
were  living in or traveled to dengue-endemic areas within the
previous  15 days and who presented with fever combined with
at  least two of the following symptoms: nausea, vomiting, skin
rash, myalgia, arthralgia, positive tourniquet test, leucopenia,
and  any other warning sign. The latter symptoms of suspected
cases  included the following: pain or abdominal discomfort,
persistent vomiting, serositis, mucosal bleeding, lethargy, agi-
tation, hepatomegaly >2 cm,  and an increase in the hematocrit
with  a simultaneous decrease in platelets.11 0 1 3;1 7(1):27–31
Following the current WHO  guidelines, suspected cases
were  classiﬁed as severe and nonsevere. Severe cases were
deﬁned  as the following: severe plasma extravasation that led
to dengue shock syndrome (DSS) or liquid accumulation with
respiratory  discomfort; severe hemorrhage that was evaluated
by  the physician; severe commitment of tissues, such as ≥1000
aminotransferases; and commitment of the central nervous
system,  heart, and other organs.11
Laboratory  methods
In the ﬁrst medical visit, individuals who presented with
the  clinical and epidemiological indications for dengue were
referred  to the laboratory for peripheral blood collection and
the  following laboratory tests: complete blood count (CBC),
erythrocyte sedimentation rate (ESR), aspartate aminotrans-
ferase  (AST), and alanine aminotransferase (ALT). To minimize
bias,  the tests were performed at a laboratory that was  associ-
ated  with the CRD. The hematocrit (Ht) parameters that were
used  to evaluate hemoconcentration included an adult man
with  a Ht > 45%, an adult woman with a Ht > 40%, and children
with  a Ht > 38%. Leukopenia was deﬁned as a leukocyte count
of  <4000/L, and thrombocytopenia was deﬁned as a platelet
count  of <150,000/L. An ESR result >20 mm/h, an AST result
>50  U/L, and an ALT result >50 U/L were considered to be high.
All  of the dengue cases were  conﬁrmed in the laboratory
by  the following: (1) serological tests using an immunoenzyme
assay (PANBIO® Indirect ELISA for anti-DENV IgM) for the cap-
ture  of anti-dengue IgM with blood that was collected between
days  5–10 after the ﬁrst fever symptoms; and (2) detection
of  the NS1 antigen of DENV using an immunoenzyme assay
(BIORAD® Platelia Dengue NS1 AssayTM) with samples that
were  collected between days 1–4 after the ﬁrst fever symp-
toms.
Treatment
Severe cases were admitted to the CRD support hospital (Hos-
pital  dos Plantadores de Cana) to receive proper clinical and
laboratory  treatment. The nonsevere cases with no alarming
clinical  signs were admitted to the CRD ambulatory clinic. The
nonsevere  cases who presented with alarming clinical signs
were  treated individually, and clinical support was  provided
at  either the hospital or ambulatory clinic according to the
severity  of each case.
Statistical  analysis
A statistical analysis was performed to evaluate the differ-
ences  in the clinical and laboratory manifestations among
individuals with dengue from the two age groups: adults and
children.  For the univariate analysis, a chi-square analysis or
Fisher’s exact test were performed for the categorical vari-
ables.  Variables with a p-value lower than 0.10 were  used for
a  multivariate logistic regression model. p-Values lower than
0.05  were considered to be signiﬁcant. A data analysis was
performed with the software program SPSS 13.0 for Windows
(Statistical Package for the Social Sciences, Chicago, IL, USA).
b r a z j i n f e c t d i s . 2 0 1 3;1  7(1):27–31  29
Table 1 – Univariate and multivariate comparative analysis of initial symptoms/signs, laboratory data and dengue
severity in adults and children with dengue.
Characteristics Adults Children Univariate Multivariate
n = 4817 n = 869 OR CI 95% p OR CI 95% p
Demographic data
Male  [n (%)] 1977 (41.0) 440 (50.6)
Age (years) (mean ± SD) 37.2 ± 15.4 9.2 ± 3.6
Initial symptoms/signs [n (%)]
Fever  4494 (93.3) 815 (93.8) 0.92 0.69–1.24 0.592
Headache 4283 (88.9) 697 (80.2) 1.98 1.64–2.39 <0.001* – – NS
Myalgia 4254 (88.3) 620 (71.3) 3.04 2.56–3.61 <0.001* 2.58 2.08–3.18 <0.001
Retro-orbital pain 2531 (52.5) 353 (40.6) 1.62 1.40–1.88 <0.001* 1.36 1.15–1.62 0.001
Prostation 2277 (47.3) 378 (43.5) 1.17 1.01–1.35 0.040* – – NS
Nausea 2187 (45.4) 216 (24.9) 2.52 2.14–2.96 <0.001* 1.92 1.60–2.30 <0.001
Vomiting 2052 (42.6) 445 (51.2) 0.71 0.61–0.82 <0.001* 0.52 0.43–0.61 <0.001
Anorexia 1428 (29.6) 152 (17.5) 1.99 1.65–2.39 <0.001* – – NS
Arthralgia 1205 (25.0) 58 (6.7) 4.67 3.55–6.14 <0.001* 3.64 2.72–4.89 <0.001
Rash 724 (15.0) 127 (14.6) 1.03 0.84–1.27 0.750
Abdominal pain 491 (10.2) 59 (6.8) 1.56 1.18–2.06 0.002* – – NS
Bleeding 134 (2.8) 9 (1.0) 2.74 1.39–5.39 0.004* – – NS
Itch 75 (1.6) 15 (1.7) 0.90 0.52–1.58 0.713
Petechiae 74 (1.5) 22 (2.5) 0.60 0.37–0.97 0.038* 0.46 0.25–0.85 0.013
Hypotension 47 (1.0) 9 (1.0) 0.94 0.46–1.93 0.870
Diarrhea 33 (0.7) 11 (1.3) 0.54 0.27–1.07 0.077
Plasma leakage 22 (0.5) 5 (0.6) 0.79 0.30–2.10 0.640
Initial laboratory data [n (%)]
Hemoconcentrationa 2350 (48.8) 206 (23.7) 3.07 2.60–3.62 <0.001* 3.04 2.53–3.65 <0.001
Thrombocytopeniab 2507 (52.0) 283 (32.6) 2.25 1.93–2.62 <0.001* 2.17 1.80–2.60 <0.001
Leucopeniac 2498 (51.9) 412 (47.4) 1.19 1.03–1.38 0.016* – – NS
High ESRd 1610 (33.4) 188 (21.6) 1.82 1.15–1.54 <0.001* 1.81 1.53–2.14 <0.001
High ASTe 1915 (39.8) 306 (35.2) 1.22 1.05–1.42 0.010* – – NS
High ALTf 1638 (34.0) 147 (16.9) 2.54 2.11–3.07 <0.001* 3.13 2.44–4.02 <0.001
Severity [n (%)]
Severe  dengue 366 (7.6) 30 (3.5) 2.29 1.57–3.35 <0.001* 1.74 1.12–2.72 <0.001
Hospitalization 696 (14.4) 55 (6.3) 2.50 1.88–3.32 <0.001* 2.21 1.59–3.06 <0.001
OR, odds ratio; CI 95%, 95% conﬁdence interval; ESR, erythrocyte sedimentation rate; AST, aspartate aminotransferase; ALT, alanine amino-
transferase; DHF, dengue hemorrhagic fever; NS, not signiﬁcant.
∗ Variables with a p-value <0.05 by univariate analysis included in multivariate analysis.
a Hemoconcentration: hematocrit >45% in men, >40% in women and >38% in children.
b Thrombocytopenia: platelets <150,000/L.
c Leucopenia: leukocytes <4000/L.
d High ESR: ESR >20 mm/h.
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esults
 total of 5686 individuals with conﬁrmed dengue were  evalu-
ted:  4817 were  adults (84.7%), and 869 were  children (15.2%).
he  majority of adults were female, who  represented 59.0%
2840)  of adults and 49.4% (429) of children. The average adult
ge  was  37.2 years, and the average child age was 9.2 years
Table  1). Adults who  were 15–19 years of age and children
ho  were 10–14 years of age were the most affected groups
Fig.  1).
Regarding the signs and symptoms that were identiﬁed in
he  ﬁrst evaluation at the CRD, classical signs, such as fever,
eadache, and myalgia, were present in over 70% of adults
nd  children with dengue (Table 1). Common clinical mani-
estations, such as retro-orbital pain, prostration, nausea, and
omiting,  were  observed in 40–50% of adults and children.A  comparison among age groups revealed that the fre-
quency  of clinical signs and symptoms was  signiﬁcantly
different between adults and children. The univariate analysis
indicated  that headache, myalgia, anorexia, retro-orbital pain,
abdominal pain, nausea, arthralgia, prostration, and bleed-
ing  were  present more  frequently in adults than in children.
However, the multivariate analysis indicated that only myal-
gia  (OR = 2.58; CI 95% = 2.08–3.18), retro-orbital pain (OR  = 1.36;
CI  95% = 1.15–1.62), nausea (OR = 1.92; CI 95% = 1.60–2.30), and
arthralgia  (OR = 3.64; CI 95% = 2.72–4.89) were signiﬁcantly
associated with adults with dengue. Vomiting (OR  = 0.52; CI
95%  = 0.43–0.61) and rash (OR = 0.46; CI 95% = 0.25–0.85) were
the  correlated symptoms in children in both the univariate
and  multivariate analyses.
Regarding  the laboratory evaluations, all of the alterations
(hemoconcentration, thrombocytopenia, leukopenia, and
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Fig. 1 – (A) Age distribution of study cohort. (B) Age
distribution of study participants 0–14 years of age.
and  the children with this dengue. Many signs and symp-increases in ESR, AST and ALT) were more  frequent in adults
than  in children. However, the multivariate analysis demon-
strated  signiﬁcant differences between adults and children
only  for the hemoconcentration (OR = 3.04; CI 95% = 2.53–3.65),
thrombocytopenia (OR = 2.17; CI 95% = 1.80–2.60), increased
ESR  (OR = 1.81; CI 95% = 1.53–2.14), and increased ALT
(OR  = 3.13; CI 95% = 2.44–4.02) (Table 1).
Adults had a higher risk for severe dengue (7.6% vs. 3.5%)
and  a higher frequency of hospitalization (14.4% vs. 6.3%) than
did  children (Table 1). The differences were signiﬁcant in both
the  univariate and multivariate analyses for severe dengue
(OR  = 1.74; CI 95% = 1.12–2.72) and hospitalization (OR = 2.21; CI
95%  = 1.59–3.06) (Table 1).
Discussion
In this study, we  detected a higher prevalence of women who
were  infected with dengue than of men. These data are similar
to  those reported by a study in Nicaragua3 and different from
other  studies.10,13,14,15 We  did not observe a signiﬁcant differ-
ence in gender when it was  correlated with the age groups.
The  children with age between 10 and 14 years old and
adults  between 15 and 19 years old were  the age groups most
prevalent  affected, similar to the data reported previously.13
In contrast to some studies,3 we found a higher preva-
lence of headache, myalgia, arthralgia, retro-orbital pain in
adults.  These ﬁndings may  be related to the difﬁculty in iden-
tifying  these signs and symptoms by the parents and the
children.  Abdominal pain is also more  common in adults, 0 1 3;1 7(1):27–31
maybe  because of the anatomo-physiological differences of
the  organs affected by dengue according to age.10
There were more  hemorrhagic manifestations in adults. It
is  believed that the primary infection acts as a protective fac-
tor  against the hemorrhagic forms in children since repeated
infections by different serotypes of the DENV, results in more
severe  manifestations.10
We  found a higher prevalence of petechiae and vomiting in
children,  as opposed to other studies.12
As reported in the literature, on Dengue’s Fever, leukope-
nia  and thrombocytopenia were the most prevalent laboratory
ﬁndings.10,16,17 The induced viral destruction or the inhibition
of  myeloid progenitor cells causes leukopenia and peripheral
destruction of platelets or destruction of megakaryocytes of
the  bone marrow by the virus, resulting in decreased produc-
tion  of platelets. There were  no clinical correlation between
thrombocytopenia and severity of Dengue.16
The literature on dengue infection indicates that an
increase in aminotransferases is a relevant laboratory
result.1,16,18 In this study, we observed that increased ALT and
AST  levels were frequent; however, there was  no correlation
between these results and the severe forms of dengue.16,19
The laboratories alterations such as thrombocytopenia and
elevation  of ALT were more  severe in adults, like published
before.10 It is noteworthy that we also did not ﬁnd respiratory
and  renal involvement in any of the cases studied.
Several studies have suggested that adults who  have been
previously primed with DENV have a favorable prognosis;
however, subsequent infections by distinct DENV serotypes
may  result in severe forms of the disease. Primary infection
could  be a protective factor against the severe forms of dengue
in  children, which may  explain the higher incidence of the
severe  forms of the disease and hospitalization in adults.10
In this study, a low prevalence of severe cases (7.0%) and
hospitalization (13.2%) was  observed. We ascribe these ﬁnd-
ings  to the efﬁcacy of the CRD Protocol, which advises patients
to  seek medical assistance immediately after the onset of
clinical  manifestations and recommends that a diagnosis be
based on the clinical evolution of the disease, thereby reduc-
ing  the risk of disease development to the severe forms, such
as  DSS.20
According to the Notiﬁable Diseases Information System
(Sistema de Informac¸ão  de Agravos de Notiﬁcac¸ão  – SINAN)
of  the Ministry of Health of Brazil, Campos dos Goytacazes
(where CRD is located) has the lowest mortality rate (1.3%)
in  Rio de Janeiro, whereas the capital has a rate of 4.8%, and
other  cities may  reach a mortality rate of 10% among severe
cases.  These ﬁndings reinforce the need to standardize pro-
grams  for the early diagnosis and treatment of dengue, such
as  the programs  conducted at the CRD.
Conclusion
The present study detected the presence of classic signs and
symptoms  (fever, headache and myalgia) in 70% of the adultstoms  of dengue manifest differently in adults and children.
Adult  patients with dengue typically present symptoms of
myalgia,  retro-orbital pain, nausea and arthralgia. Children
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Mumbai  and predictive markers for dengue shock syndrome.b r a z j i n f e c t d i
anifests mainly with vomiting and petechiae. There were  no
ifferences between these two age groups about the presence
f  fever, rash, itch, hypotension and diarrhea. Hemoconcen-
ration, thrombocytopenia, ALT and ESR elevation occurred
redominantly among adults. Adult patients also had a higher
isk  of severe dengue and an increased frequency of hospital-
zation.
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